Boehringer Ingelheim

Senior AI Engineer for Cybersecurity Detection

Boehringer Ingelheim
Apply
2 months ago
Philippines (city not specified)Senior

Responsibilities

  • Design and maintain multi-agent architectures for security incident triage and decision support.
  • Develop and refine machine learning models to assess and score incidents.
  • Integrate and orchestrate tools and agents to automate and enrich triage workflows.
  • Operationalize, monitor, troubleshoot, and continuously improve AI agents in production.
  • Integrate agent-based systems with enterprise protocols, APIs, and data sources.
  • Document system logic, workflows, system designs, and findings for technical and non-technical stakeholders.
  • Collaborate with cybersecurity experts, data scientists, technology teams, and project stakeholders.

Requirements

  • Bachelor's or Master's degree in Computer Science, Data Science, Artificial Intelligence, Software Engineering, or a related field, or equivalent professional experience.
  • At least 5 years of experience in Data Science, AI Engineering, Machine Learning, or related technical roles.
  • Proven experience designing, building, and deploying agent-based AI systems with multi-agent orchestration and tool integration.
  • Hands-on expertise with Large Language Models, Retrieval-Augmented Generation, machine learning, AI-driven decision support, and multi-agent architectures.
  • Strong proficiency in Python and relevant programming languages.
  • Experience with Docker and OpenShift; familiarity with MLflow or similar model lifecycle platforms is valued.
  • Experience integrating enterprise protocols and APIs and building robust, secure, and scalable AI solutions.
  • Certifications such as Azure AI Engineer or AWS Machine Learning are valued.
  • Strong troubleshooting, analytical, documentation, communication, and cross-functional collaboration skills.

Tech Stack

DockerMLflowOpenShiftPython
Boehringer Ingelheim

About Boehringer Ingelheim

10,000+ employees

Boehringer Ingelheim develops and manufactures prescription medicines for humans and animal health products, and provides biopharmaceutical contract manufacturing services. The family-owned company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. Its portfolio spans areas such as cardiovascular and metabolic diseases, respiratory disorders, oncology, and vaccines for livestock and companion animals, with products marketed globally.

Contact me